The overall goal of the proposed research is to continue to work towards determining the optimum care for children with all types of cancer. The research mechanism involves participation by pediatric investigators at the Bowman Gray School of Medicine in collaborative multidisciplinary clinical oncology protocols of the Pediatric Oncology Group as well as continued collaboration with other centers in North and South Carolina. The proposed research grant will allow for the continued participation of the Bowman Gray School of Medicine as a full member of the Pediatric Oncology Group and will provide support for our affiliate institution in Greenville, South Carolina. As a natural outgrowth of our expanding program and activities, this grant will provide for direct independent funding of the Bowman Gray School of Medicine (formerly funded as an affiliate of Duke University). Our accomplishments in the past years are described in detail in the grant proposal. Our institutional goals for the five year period of this grant include: (1) continuing our record of increasing accrual and our excellent clinical contribution to the POG, including our record of 100% patient evaluability and protocol compliance; (2) expanding our institutional involvement in the design and development of POG leukemia studies; (3) further institutional development of our interest in brain tumors and our neuro-oncology clinic, leading to increasing patient enrollment on brain tumor protocols and to investigator roles in the POG Brain Tumor Committee; (4) continuation of our strong involvement in POG Hodgkin's disease activities; (5) increasing development of late effects studies and active participation with the POG Late Effects Committee; (6) significant expansion of our role in the POG Cytogenetics Committee and the development of a second POG Cytogenetics Reference Laboratory at Bowman Gray; (7) continued major contributions to the administrative aspects of the POG, as presently exemplified by our roles on the Executive and Institutional Performance Review Committees. Finally, we plan to continue our very close working relationship with our affiliate institution in Greenville, SC with the goal of assuring optimal clinical care for all children with cancer in our referral area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA053128-03
Application #
3558990
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1991-04-01
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Wacker, Pierre; Land, Vita J; Camitta, Bruce M et al. (2007) Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol 29:627-32
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Saylors 3rd, R L; Stine, K C; Sullivan, J et al. (2001) Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 19:3463-9
Schneider, N R; Carroll, A J; Shuster, J J et al. (2000) New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 96:2543-9
Austin, G E; Alvarado, C S; Austin, E D et al. (1998) Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia. Am J Clin Pathol 110:575-81
Weiner, M A; Leventhal, B; Brecher, M L et al. (1997) Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 15:2769-79
Martin, P L; Look, A T; Schnell, S et al. (1996) Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 18:113-21
Weiner, M A; Landmann, R G; DeParedes, L et al. (1995) Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease. J Pediatr Hematol Oncol 17:338-41
Pettenati, M J; Rao, N; Wofford, M et al. (1994) Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493). Cancer Genet Cytogenet 75:6-10